跳至主要内容
临床试验/NCT05971901
NCT05971901招募中不适用

A Combinatorial Biomarker for Infection Diagnosis in Children

Universität des Saarlandes4 个研究点 分布在 1 个国家目标入组 770 人开始时间: 2023年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
770
试验地点
4
主要终点
Antibiotics

研究概览

简要总结

To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement.

Secondary objectives:

  • Qualitative evaluation of indication as well as adherence to the test result.
  • Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
5 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Suspicion of acute bacterial or viral infection
  • Requirement of at least one BV test during medical presentation

排除标准

  • lack of informed consent

结局指标

主要结局

Antibiotics

时间窗: up to 30 days

Number of participants treated with antibiotics

次要结局

  • Antibiotic duration(up to 30 days)
  • Complications(up to 30 days)
  • Hospitalization(up to 30 days)
  • Tests(up to 30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cihan Papan

Principial Investigator

Universität des Saarlandes

研究点 (4)

Loading locations...

相似试验

A Combinatorial Biomarker for Infection Diagnosis in... | 临床试验